At a glance
ClinicalIndex Comparison Record- ✓Confirmed diagnosis of Autism Spectrum Disorder (ASD) by DSM-5 criteria and Gilliam Asperger Disorder Scale (GADS)
- ✓Adequate understanding and cooperation for the rTMS procedure
- ✕Significant anxiety or contact avoidance that would prevent cooperation with the procedure
- ✕Known diagnosis of seizures
- ✕Metallic implants or devices in the head or neck area
- ✕Pregnancy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhancement of Behavioral and Cognitive Outcomes in Autism Spectrum Disorder Via Neurostimulation
In Brief
A clinical study evaluating Trans Cranial Magnetic Stimulation for Autism Spectrum Disorder. Completed, enrolled 16 participants across 1 site.
Detailed Summary
Autism spectrum disorder (ASD) encompasses a range of limitations in reciprocal social and communicative milestones, as well as restrictive and/or repetitive patterns of behavior which lead to significant functional challenges impacting individuals throughout their lifespan. There are major shortcomings in the existing pharmacological interventions; they are of limited efficacy, target a subset of problematic behaviors, and fail to improve social cognition. To overcome these limitations and improve outcomes, the investigators study the use of neurostimulation to mitigate the social and cognitive manifestations of ASD.
Study Details
Timeline
Interventions
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neurostimulation technique that alters cortical excitability by repeated induction of electromagnetic activity. FDA approved for depression, rTMS is a promising tool in the field of neuropsychiatry with an excellent safety profile.